» Articles » PMID: 18086816

Intracellular Interleukin-1alpha Mediates Interleukin-8 Production Induced by Chlamydia Trachomatis Infection Via a Mechanism Independent of Type I Interleukin-1 Receptor

Overview
Journal Infect Immun
Date 2007 Dec 19
PMID 18086816
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

Chlamydia trachomatis infection induces a wide array of inflammatory cytokines and chemokines, which may contribute to chlamydia-induced pathologies. However, the precise mechanisms by which Chlamydia induces cytokines remain unclear. Here we demonstrate that the proinflammatory cytokine interleukin-1alpha (IL-1alpha) plays an essential role in chlamydial induction of the chemokine IL-8. Cells deficient in IL-1alpha expression or IL-1alpha-competent cells treated with IL-1alpha-specific small interfering RNA failed to produce IL-8 in response to chlamydial infection. However, neutralization of extracellular IL-1alpha or blockade of or deficiency in type I IL-1 receptor (IL-1RI) signaling did not affect chlamydial induction of IL-8 in cells capable of producing IL-1alpha. These results suggest that IL-1alpha can mediate the chlamydial induction of IL-8 via an intracellular mechanism independent of IL-1RI, especially during the early stage of the infection cycle. This conclusion is further supported by the observations that expression of a transgene-encoded full-length IL-1alpha fusion protein in the nuclei enhanced IL-8 production and that nuclear localization of chlamydia-induced precursor IL-1alpha correlated with chlamydial induction of IL-8. Thus, we have identified a novel mechanism for chlamydial induction of the chemokine IL-8.

Citing Articles

-driven ISG15 expression dampens the immune response of epithelial cells independently of ISGylation.

Wu Y, Liu C, Tang C, Niragire B, Levy-Zauberman Y, Adapen C mBio. 2024; 15(11):e0240124.

PMID: 39345209 PMC: 11559041. DOI: 10.1128/mbio.02401-24.


Preclinical screen for protection efficacy of chlamydial antigens that are immunogenic in humans.

Lu C, Wang J, Zhong G Infect Immun. 2023; 91(11):e0034923.

PMID: 37889004 PMC: 10652899. DOI: 10.1128/iai.00349-23.


IL-23 receptor signaling licenses group 3-like innate lymphoid cells to restrict a live-attenuated oral Chlamydia vaccine in the gut.

He Y, Wang Y, He R, Abdelsalam A, Zhong G Infect Immun. 2023; 91(11):e0037123.

PMID: 37850749 PMC: 10652955. DOI: 10.1128/iai.00371-23.


induces the transcriptional activity of host YAP in a Hippo-independent fashion.

Caven L, Brinkworth A, Carabeo R Front Cell Infect Microbiol. 2023; 13:1098420.

PMID: 36923592 PMC: 10008951. DOI: 10.3389/fcimb.2023.1098420.


The role of occlusion and micro-incontinence in the pathogenesis of penile lichen sclerosus: an observational study of pro-inflammatory cytokines' gene expression.

Czajkowski M, Wierzbicki P, Kotulak-Chrzaszcz A, Czajkowska K, Bolcewicz M, Klacz J Int Urol Nephrol. 2022; 54(4):763-772.

PMID: 35103930 PMC: 8924098. DOI: 10.1007/s11255-022-03130-7.


References
1.
Greene W, Xiao Y, Huang Y, McClarty G, Zhong G . Chlamydia-infected cells continue to undergo mitosis and resist induction of apoptosis. Infect Immun. 2003; 72(1):451-60. PMC: 343958. DOI: 10.1128/IAI.72.1.451-460.2004. View

2.
Hybiske K, Stephens R . Mechanisms of Chlamydia trachomatis entry into nonphagocytic cells. Infect Immun. 2007; 75(8):3925-34. PMC: 1952008. DOI: 10.1128/IAI.00106-07. View

3.
Zhong G, Toth I, Reid R, Brunham R . Immunogenicity evaluation of a lipidic amino acid-based synthetic peptide vaccine for Chlamydia trachomatis. J Immunol. 1993; 151(7):3728-36. View

4.
Elbashir S, Martinez J, Patkaniowska A, Lendeckel W, Tuschl T . Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate. EMBO J. 2001; 20(23):6877-88. PMC: 125328. DOI: 10.1093/emboj/20.23.6877. View

5.
Lotze M, Tracey K . High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol. 2005; 5(4):331-42. DOI: 10.1038/nri1594. View